INS and obesity disorder: Three weeks of combined treatment of resveratrol and rosiglitazone did not alter body weight changes in aKQ mice after obesity induction, but caused slightly worse insulin sensitivity and more favorable glucose tolerance in aKQ mice (Figure 5A–C).